Technical Analysis for KRYS - Krystal Biotech, Inc.

Grade Last Price % Change Price Change
B 71.65 -13.91% -11.58
KRYS closed down 13.91 percent on Thursday, March 4, 2021, on 1.72 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical KRYS trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
New Downtrend Bearish 0.00%
Stochastic Sell Signal Bearish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Multiple of Ten Bearish Other 0.00%
Down 3 Days in a Row Weakness 0.00%
Overbought Stochastic Strength -13.91%
Jack-in-the-Box Bullish Bullish Swing Setup -14.98%
Older End-of-Day Signals for KRYS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 ATRs about 5 hours ago
Fell Below 20 DMA about 5 hours ago
Down 10% about 6 hours ago
20 DMA Support about 7 hours ago
Down 1 ATR about 8 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Krystal Biotech, Inc. Description

Krystal Biotech, Inc. gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases. The Company’s products include KB103 and KB104.The Compnay's KB103 is in preclinical development to treat dystrophic epidermolysis bullosa, or DEB, a rare and severe genetic disease. The Compnay's KB104 is to treat Netherton Syndrome, a severe form of ichthyosis, which is a family of genetic skin disorders associated with thickened scaly skin and characterized by chronic skin inflammation, itchiness, dehydration and stunted growth.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Clinical Development Rare Diseases Inflammation Gene Therapy Genetic Disease Herpes Genodermatoses Herpes Simplex Herpes Simplex Virus Dehydration Epidermolysis Bullosa Dermatological Diseases Ichthyosis Itchiness Netherton Syndrome Skin Inflammation

Is KRYS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 87.025
52 Week Low 33.0848
Average Volume 155,597
200-Day Moving Average 51.94
50-Day Moving Average 69.42
20-Day Moving Average 75.26
10-Day Moving Average 79.40
Average True Range 5.17
ADX 26.27
+DI 22.05
-DI 23.22
Chandelier Exit (Long, 3 ATRs ) 71.52
Chandelier Exit (Short, 3 ATRs ) 77.89
Upper Bollinger Band 85.83
Lower Bollinger Band 64.69
Percent B (%b) 0.33
BandWidth 28.09
MACD Line 3.29
MACD Signal Line 3.44
MACD Histogram -0.1442
Fundamentals Value
Market Cap 1.41 Billion
Num Shares 19.7 Million
EPS -1.20
Price-to-Earnings (P/E) Ratio -59.76
Price-to-Sales 0.00
Price-to-Book 3.19
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 92.79
Resistance 3 (R3) 94.89 89.94 89.26
Resistance 2 (R2) 89.94 84.56 88.89 88.09
Resistance 1 (R1) 80.80 81.24 78.33 78.70 86.91
Pivot Point 75.85 75.85 74.62 74.80 75.85
Support 1 (S1) 66.71 70.47 64.24 64.61 56.39
Support 2 (S2) 61.76 67.15 60.71 55.21
Support 3 (S3) 52.62 61.76 54.04
Support 4 (S4) 50.52